SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-21-011442
Filing Date
2021-04-02
Accepted
2021-04-02 17:16:30
Documents
6
Period of Report
2021-05-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A nc10022256x1_def14a.htm DEF 14A 724362
2 logo_sprucebio.jpg GRAPHIC 26607
3 nc10022256x1_piecharts01.jpg GRAPHIC 137499
4 nc10022256x1_proxycard0x2.jpg GRAPHIC 481522
5 nc10022256x1_proxycard0x3.jpg GRAPHIC 411806
6 sig_rking.jpg GRAPHIC 21049
  Complete submission text file 0001140361-21-011442.txt   2209607
Mailing Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104
Business Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104 (415) 294-1687
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

IRS No.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39594 | Film No.: 21802910
SIC: 2834 Pharmaceutical Preparations